+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Interventional Cardiology Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • October 2020
  • Region: Global
  • TechNavio
  • ID: 5205163
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Interventional Cardiology Market 2020-2024

The publisher has been monitoring the interventional cardiology market and it is poised to grow by $ 4.40 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on the interventional cardiology market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing cardiac disorders and rising older population, advances in technology, and growing demand for MI procedures. In addition, increasing cardiac disorders and rising older population is anticipated to boost the growth of the market as well.

The interventional cardiology market analysis includes product segment and geographical landscapes.

The interventional cardiology market is segmented as below:

By Product
  • Coronary stents
  • PTCA balloon catheters
  • Interventional guidewires
  • Interventional imaging systems
  • Others

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the emergence of bioabsorbable stents as one of the prime reasons driving the interventional cardiology market growth during the next few years. Also, the growing popularity of hybrid procedures and focus on emerging countries will lead to sizable demand in the market.

The interventional cardiology market report covers the following areas:
  • Interventional cardiology market sizing
  • Interventional cardiology market forecast
  • Interventional cardiology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interventional cardiology market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Medtronic Plc, MicroPort Scientific Corp., Teleflex Inc., and Terumo Corp. Also, the interventional cardiology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Coronary stents - Market size and forecast 2019-2024
  • PTCA balloon catheters - Market size and forecast 2019-2024
  • Interventional guidewires - Market size and forecast 2019-2024
  • Interventional imaging systems - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user
  • Market segments
  • Comparison by End user
  • ASCs - Market size and forecast 2019-2024
  • Hospitals - Market size and forecast 2019-2024
  • Physicians' office laboratories - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape
  • Overview

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Teleflex Inc.
  • Terumo Corp.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Key Finding 9
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Product - Market share 2019-2024 (%)
  • Comparison by Product
  • Coronary stents - Market size and forecast 2019-2024 ($ million)
  • Coronary stents - Year-over-year growth 2019-2024 (%)
  • PTCA balloon catheters - Market size and forecast 2019-2024 ($ million)
  • PTCA balloon catheters - Year-over-year growth 2019-2024 (%)
  • Interventional guidewires - Market size and forecast 2019-2024 ($ million)
  • Interventional guidewires - Year-over-year growth 2019-2024 (%)
  • Interventional imaging systems - Market size and forecast 2019-2024 ($ million)
  • Interventional imaging systems - Year-over-year growth 2019-2024 (%)
  • Others - Market size and forecast 2019-2024 ($ million)
  • Others - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Product
  • End user - Market share 2019-2024 (%)
  • Comparison by End user
  • ASCs - Market size and forecast 2019-2024 ($ million)
  • ASCs - Year-over-year growth 2019-2024 (%)
  • Hospitals - Market size and forecast 2019-2024 ($ million)
  • Hospitals - Year-over-year growth 2019-2024 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • B. Braun Melsungen AG - Overview
  • B. Braun Melsungen AG - Business segments
  • B. Braun Melsungen AG - Key offerings
  • B. Braun Melsungen AG - Key customers
  • B. Braun Melsungen AG - Segment focus
  • Becton, Dickinson and Co. - Overview
  • Becton, Dickinson and Co. - Business segments
  • Becton, Dickinson and Co. - Key offerings
  • Becton, Dickinson and Co. - Key customers
  • Becton, Dickinson and Co. - Segment focus
  • BIOTRONIK SE & Co. KG - Overview
  • BIOTRONIK SE & Co. KG - Product and service
  • BIOTRONIK SE & Co. KG - Key offerings
  • BIOTRONIK SE & Co. KG - Key customers
  • BIOTRONIK SE & Co. KG - Segment focus
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Key customers
  • Boston Scientific Corp. - Segment focus
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Key customers
  • Cardinal Health Inc. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • MicroPort Scientific Corp. - Overview
  • MicroPort Scientific Corp. - Business segments
  • MicroPort Scientific Corp. - Key offerings
  • MicroPort Scientific Corp. - Key customers
  • MicroPort Scientific Corp. - Segment focus
  • Teleflex Inc. - Overview
  • Teleflex Inc. - Business segments
  • Teleflex Inc. - Key offerings
  • Teleflex Inc. - Key customers
  • Teleflex Inc. - Segment focus
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Key customers
  • Terumo Corp. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global interventional cardiology market: Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Medtronic Plc, MicroPort Scientific Corp., Teleflex Inc., and Terumo Corp.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the emergence of bioabsorbable stents.'

According to the report, one of the major drivers for this market is the increasing cardiac disorders and rising older population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Co.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Teleflex Inc.
  • Terumo Corp.